Advanced search
Publication Cover
Infection and Drug Resistance Volume 12, 2019 - Issue
Submit an article Journal homepage
940
Views
44
CrossRef citations to date
0
Altmetric
Review

Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review

Taher Azimi1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;2 Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0213-5227
ORCID Icon,
Mehrdad Mosadegh2 Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
,
Mohammad Javad Nasiri1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranORCID Iconhttps://orcid.org/0000-0002-3279-0671
ORCID Icon,
Sahar Sabour3 Department of Microbiology, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran
,
Samira Karimaei2 Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
&
Ahmad Nasser4 Clinical Microbiology Research Center, Ilam University of Medical Science, Ilam, Iran
Pages 2943-2959 | Published online: 17 Sep 2019

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mohanad Mahmoud & Yurong Tan. (2023) New advances in the treatments of drug-resistant tuberculosis. Expert Review of Anti-infective Therapy 21:8, pages 863-870.
Read now
Paulina Śliwka, Marta Ochocka & Aneta Skaradzińska. (2022) Applications of bacteriophages against intracellular bacteria. Critical Reviews in Microbiology 48:2, pages 222-239.
Read now
Avijit Goswami, Pallavi Raj Sharma & Rachit Agarwal. (2021) Combatting intracellular pathogens using bacteriophage delivery. Critical Reviews in Microbiology 47:4, pages 461-478.
Read now
Majid Taati Moghadam, Amin Khoshbayan, Zahra Chegini, Iman Farahani & Aref Shariati. (2020) Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials. Drug Design, Development and Therapy 14, pages 1867-1883.
Read now

Articles from other publishers (40)

Vadim Vadimovich Avdeev, Victor Vladimirovich Kuzin, Mikhail Aleksandrovich Vladimirsky & Irina Anatol’evna Vasilieva. (2023) Experimental Studies of the Liposomal Form of Lytic Mycobacteriophage D29 for the Treatment of Tuberculosis Infection. Microorganisms 11:5, pages 1214.
Crossref
Anne E. Friedland, Eileen K. Maziarz, Cameron R. Wolfe, Chetan B. Patel, Priyesh Patel, Carmelo A. Milano, Jacob N. Schroder, Mani A. Daneshmand, Richard J. WallaceJr.Jr., Barbara D. Alexander & Arthur W. Baker. (2023) Epidemiology, management, and clinical outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. American Journal of Transplantation.
Crossref
Joshua D. Jones, Helen J. Stacey, Arlene Brailey, Mehrunisha Suleman & Ross J. Langley. (2023) Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom. Antibiotics 12:3, pages 502.
Crossref
Sunil Kumar, Shashikanta Sau, Puja Kumari Agnivesh, Arnab Roy & Nitin Pal Kalia. (2023) Role of transcription termination factor Rho in anti-tuberculosis drug discovery. Drug Discovery Today 28:3, pages 103490.
Crossref
Jiayu Shang, Xubo Tang & Yanni Sun. (2023) PhaTYP: predicting the lifestyle for bacteriophages using BERT. Briefings in Bioinformatics 24:1.
Crossref
Zulipikaer Maimaiti, Zhuo Li, Chi Xu, Jiying Chen & Wei Chai. (2023) Global trends and hotspots of phage therapy for bacterial infection: A bibliometric visualized analysis from 2001 to 2021. Frontiers in Microbiology 13.
Crossref
Mohammad Naiyaz Ahmad, Satyaveni Malasala, Nanduri Srinivas, Arunava Dasgupta & Sidharth Chopra. 2023. Tuberculosis. Tuberculosis 571 600 .
Fatemeh Zeynali kelishomi, Susan Khanjani, Fatemeh Fardsanei, Hediyeh Saghi Sarabi, Farhad Nikkhahi & Behzad Dehghani. (2022) Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review. BMC Infectious Diseases 22:1.
Crossref
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, Yasmine El-Garawany, Sulaiman Anagreyyah, Yaser Alnafea, Abdulaziz M. Almuzaini, Waleed Alwarhi, Mohammed Rawway & Abdelmaged Draz. (2022) The Development of Technology to Prevent, Diagnose, and Manage Antimicrobial Resistance in Healthcare-Associated Infections. Vaccines 10:12, pages 2100.
Crossref
Ngozi Joannes Anyaegbunam, Chijioke Chinedu Anekpo, Zikora Kizito Glory Anyaegbunam, Yandev Doowuese, Chinwe Blessing Chinaka, Oluchi Joannes Odo, Hyelnaya Cletus Sharndama, Onyekachi Philomena Okeke & Ifeanyi Elibe Mba. (2022) The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects. Microbiological Research 264, pages 127155.
Crossref
Olivia Jacobs, Nikki Gentle, Christopher Ealand & Bavesh Kana. (2022) Complete Genome Sequence of Mycobacteriophage IgnatiusPatJac. Microbiology Resource Announcements 11:10.
Crossref
Janis H. Doss, Nazir Barekzi & David T. Gauthier. (2022) Improving high-throughput techniques for bacteriophage discovery in multi-well plates. Journal of Microbiological Methods 200, pages 106542.
Crossref
Mohmmad Imran, Mohammad Naiyaz Ahmad, Arunava Dasgupta, Preeti Rana, Nanduri Srinivas & Sidharth Chopra. (2022) Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens. Future Medicinal Chemistry 14:15, pages 1133-1148.
Crossref
Jiayu Shang, Xubo Tang, Ruocheng Guo & Yanni Sun. (2022) Accurate identification of bacteriophages from metagenomic data using Transformer. Briefings in Bioinformatics 23:4.
Crossref
Sepideh Hosseiniporgham & Leonardo A. Sechi. (2022) A Review on Mycobacteriophages: From Classification to Applications. Pathogens 11:7, pages 777.
Crossref
Ahmad Nasser, Mehrdad Mosadegh, Taher Azimi & Aref Shariati. (2022) Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population. Molecular and Cellular Pediatrics 9:1.
Crossref
Laura E. Gleeson & Grant Waterer. (2022) Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection. Breathe 18:2, pages 210171.
Crossref
Naveen Chaudhary, Balvinder Mohan, Ravimohan S. Mavuduru, Yashwant Kumar & Neelam Taneja. (2022) Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India. Journal of Applied Microbiology 132:4, pages 3387-3404.
Crossref
Aref Shariati, Soheil Vesal, Amin Khoshbayan, Parnian Goudarzi, Davood Darban-Sarokhalil, Shabnam Razavi, Mojtaba Didehdar & Zahra Chegini. (2022) Novel strategies for inhibition of bacterial biofilm in chronic rhinosinusitis. Journal of Applied Microbiology 132:4, pages 2531-2546.
Crossref
Sarah J. Chalmers & Timothy R. Aksamit. (2022) New therapies for nontuberculous mycobacterial lung infection. Current Opinion in Infectious Diseases 35:2, pages 176-184.
Crossref
Shreya Sengupta, Niketa Bhawsinghka, Rahul Shaw, Madhu Manti Patra & Sujoy K. Das Gupta. (2022) Mycobacteriophage D29 induced association of Mycobacterial RNA polymerase with ancillary factors leads to increased transcriptional activity. Microbiology 168:3.
Crossref
Andreas H. Diacon, Carlos A. Guerrero-Bustamante, Bernd Rosenkranz, Francisco J. Rubio Pomar, Naadira Vanker & Graham F. Hatfull. (2022) Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?. Respiration 101:1, pages 1-15.
Crossref
Christopher G. Shield, Benjamin M. C. Swift, Timothy D. McHugh, Rebekah M. Dedrick, Graham F. Hatfull & Giovanni Satta. (2021) Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment. Microorganisms 9:11, pages 2366.
Crossref
Anna Grzegorzewicz & Mariola Paściak. (2021) The key factors contributing to the risk, diagnosis and treatment of non-tuberculous mycobacterial opportunistic infections. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 696-710.
Crossref
Adele Crane, Cyril J Versoza, Tiana Hua, Rohan Kapoor, Lillian Lloyd, Rithik Mehta, Jueliet Menolascino, Abraham Morais, Saige Munig, Zeel Patel, Daniel Sackett, Brandon Schmit, Makena Sy & Susanne P Pfeifer. (2021) Phylogenetic relationships and codon usage bias amongst cluster K mycobacteriophages. G3 Genes|Genomes|Genetics 11:11.
Crossref
Véronique Ongenae, Ariane Briegel & Dennis Claessen. (2021) Cell wall deficiency as an escape mechanism from phage infection. Open Biology 11:9.
Crossref
Wei Yan, Parikshit Banerjee, Miao Xu, Subhankar Mukhopadhyay, Margaret Ip, Nicholas B. Carrigy, David Lechuga-Ballesteros, Kenneth Kin Wah To & Sharon S.Y. Leung. (2021) Formulation strategies for bacteriophages to target intracellular bacterial pathogens. Advanced Drug Delivery Reviews 176, pages 113864.
Crossref
Mohamed S. Fayez, Toka A. Hakim, Mona M. Agwa, Mohamed Abdelmoteleb, Rania G. Aly, Nada N. Montaser, Abdallah S. Abdelsattar, Nouran Rezk & Ayman El-Shibiny. (2021) Topically Applied Bacteriophage to Control Multi-Drug Resistant Klebsiella pneumoniae Infected Wound in a Rat Model. Antibiotics 10:9, pages 1048.
Crossref
Israa M. Abd-Allah, Ghadir S. El-Housseiny, Ibrahim S. Yahia, Khaled M. Aboshanab & Nadia A. Hassouna. (2021) Rekindling of a Masterful Precedent; Bacteriophage: Reappraisal and Future Pursuits. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Varun Rakeshbhai Bavda, Aditi Yadav & Vikas Jain. (2021) Decoding the Molecular Properties of Mycobacteriophage D29 Holin Provides Insights into Holin Engineering. Journal of Virology 95:10.
Crossref
Abrar Senhaji-Kacha, Jaime Esteban & Meritxell Garcia-Quintanilla. (2021) Considerations for Phage Therapy Against Mycobacterium abscessus. Frontiers in Microbiology 11.
Crossref
Anna Allué-Guardia, Rajagopalan Saranathan, John Chan & Jordi B. Torrelles. (2021) Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis. International Journal of Molecular Sciences 22:2, pages 735.
Crossref
Elizabeth Whittaker & Surinder K. Tamne. 2021. Tuberculosis in Clinical Practice. Tuberculosis in Clinical Practice 15 28 .
Shamim I. Ahmad. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines 663 692 .
Ines Joao, Helena Bujdáková & Luisa Jordao. (2020) Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. Antibiotics 9:11, pages 771.
Crossref
Graham F. Hatfull. (2020) Actinobacteriophages: Genomics, Dynamics, and Applications. Annual Review of Virology 7:1, pages 37-61.
Crossref
Michal Meir & Daniel Barkan. (2020) Alternative and Experimental Therapies of Mycobacterium abscessus Infections. International Journal of Molecular Sciences 21:18, pages 6793.
Crossref
Grant Waterer. (2020) Beyond antibiotics for pulmonary nontuberculous mycobacterial disease. Current Opinion in Pulmonary Medicine 26:3, pages 260-266.
Crossref
Clara M. Bento, Maria Salomé Gomes & Tânia Silva. (2020) Looking beyond Typical Treatments for Atypical Mycobacteria. Antibiotics 9:1, pages 18.
Crossref
Bernadette Dian Novita. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment 251 266 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.